Fulcrum Therapeutics, Inc. (NASDAQ:FULC) appears in 168 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 557,011 | 15.03% | $0.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 1,180,111 | 21.93% | $0.00 |
| TCG Crossover Management, LLC | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | -81,216 | -37.99% | $0.00 |
| RA CAPITAL MANAGEMENT, L.P. | 31 Dec, 2025 | 0 | -4,175,139 | -40.82% | $0.00 |
| BRAIDWELL LP | 31 Dec, 2025 | 0 | 2,841,734 | 1,294.71% | $0.00 |
| HSBC HOLDINGS PLC | 31 Dec, 2025 | 0 | 32,718 | 60.81% | $0.00 |
| Nantahala Capital Management, LLC | 31 Dec, 2025 | 0 | -377,438 | -8.08% | $0.00 |
| ADAR1 Capital Management, LLC | 31 Dec, 2025 | 0 | 2,165,886 | 634.02% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 448 | 0.00% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 560,088 | 18.67% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | 2,398,232 | 0.00% | $0.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 0 | 464,332 | 32.04% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | 1,950,000 | 0.00% | $0.00 |
| GSK plc | 31 Dec, 2025 | 0 | 1,785,714 | 0.00% | $0.00 |
| First Turn Management, LLC | 31 Dec, 2025 | 0 | 1,892,683 | 0.00% | $0.00 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 31 Dec, 2025 | 0 | -732,000 | -30.10% | $0.00 |
| Ikarian Capital, LLC | 31 Dec, 2025 | 0 | 86,247 | 6.69% | $0.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 0 | 352,448 | 41.24% | $0.00 |
| Aberdeen Group plc | 31 Dec, 2025 | 0 | 1,116,066 | 808.97% | $0.00 |